Welcome to CDC Stacks | Evaluation of Patients under Investigation for MERS-CoV Infection, United States, January 2013–October 2014 - 31830 | CDC Public Access | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Evaluation of Patients under Investigation for MERS-CoV Infection, United States, January 2013–October 2014
Filetype[PDF - 922.57 KB]


Details:
No Related Documents.
You May Also Like:
  1. Updated information and guidelines for evaluation of patients for Middle East respiratory syndrome coronavirus (MERS-CoV) infection
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    June 11, 2015
    Series:
    HAN ; 380
    Description:
    June 11, 2015, 14:00 ET (2:00 PM ET) : CDCHAN-00380 : The Centers for Disease Control and Prevention (CDC) continues to work with the World Health Organization (WHO) and other partners to closely monitor Middle East Respiratory Syndrome Coronavirus (...
    File Type:
    Filetype[PDF - 200.91 KB]
  2. Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for Middle East Respiratory Syndrome coronavirus (MERS-CoV) – Version 2.1
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    June 2015
    Description:
    This is an updated version of the interim guidance document issued by the Centers for Disease Control and Prevention (CDC) January 2014. CDC has revised the interim guidance based on comments received from public health partners, healthcare providers...
    File Type:
    Filetype[PDF - 393.58 KB]
  3. Interim guidelines for collection, processing and transport of clinical specimens from patients under investigation for Middle East Respiratory Syndrome (MERS)
    Corporate Author:
    Centers for Disease Control and Prevention (U.S.)
    Published:
    June 7, 2013
    Description:
    Before collecting and shipping specimens for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) testing, determine whether the patient meets the current definition for MERS “Patient Under Investigation” prepared by the Centers for Disease Co...
    File Type:
    Filetype[PDF - 179.59 KB]
  4. Serologic Assessment of Possibility for MERS-CoV Infection in Equids
    Personal Author:
    Meyer, Benjamin; García-Bocanegra, Ignacio; Wernery, Ulrich; Wernery, Renate; Sieberg, Andrea; Müller, Marcel A.; Drexler, Jan Felix; Drosten, Christian; Eckerle, Isabella;
    Published:
    2015
    Source:
    Emerg Infect Dis. 21(1):181-182.
    File Type:
    Filetype[PDF - 302.52 KB]
  5. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
    Personal Author:
    Arabi, Yaseen M.; Hajeer, Ali H.; Luke, Thomas; Raviprakash, Kanakatte; Balkhy, Hanan; Johani, Sameera; Al-Dawood, Abdulaziz; Al-Qahtani, Saad; Al-Omari, Awad; Al-Hameed, Fahad; Hayden, Frederick G.; Fowler, Robert; Bouchama, Abderrezak; Shindo, Nahoko; Al-Khairy, Khalid; Carson, Gail; Taha, Yusri; Sadat, Musharaf; Alahmadi, Mashail;
    Published:
    Sep 2016
    Source:
    Emerg Infect Dis. 22(9):1554-1561.
    Description:
    We explored the feasibility of collecting convalescent plasma for passive immunotherapy of Middle East respiratory syndrome coronavirus (MERS-CoV) infection by using ELISA to screen serum samples from 443 potential plasma donors: 196 patients with su...
    File Type:
    Filetype[PDF - 1.17 MB]